Fig. 1From: Designing and development of multi-epitope chimeric vaccine against Helicobacter pylori by exploring its entire immunogenic epitopes: an immunoinformatic approachPhase wise schematic presentation of the detailed workflow used in this study. Phase 1 consisted of the selection of proteins and epitopes. Phase 2 involved the construction of a vaccine candidate, structure prediction, and validation. Phase 3 involved docking with the immune receptor, immune simulation, and in-silico expressionBack to article page